MTCLX
Price
$77.86
Change
+$0.05 (+0.06%)
Updated
Oct 17 closing price
SLMCX
Price
$132.73
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Ad is loading...

MTCLX vs SLMCX

Header iconMTCLX vs SLMCX Comparison
Open Charts MTCLX vs SLMCXBanner chart's image
MFS Technology R6
Price$77.86
Change+$0.05 (+0.06%)
VolumeN/A
CapitalizationN/A
Columbia Seligman Tech & Info A
Price$132.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MTCLX vs SLMCX Comparison Chart
Loading...
VS
MTCLX vs. SLMCX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTCLX is a Buy and SLMCX is a Buy.

FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 13.6B vs. MTCLX (2.02B). MTCLX (0.00) and SLMCX (0.00) have matching dividends . MTCLX was incepted earlier than SLMCX: MTCLX (12 years) vs SLMCX (41 years). MTCLX is a more actively managed with annual turnover of: 44.00 vs. SLMCX (13.00). MTCLX has a lower initial minimum investment than SLMCX: MTCLX (0) vs SLMCX (2000). MTCLX annual gain was more profitable for investors over the last year : 35.32 vs. SLMCX (27.03). SLMCX return over 5 years is better than : 70.82 vs. MTCLX (63.33).
MTCLXSLMCXMTCLX / SLMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years41 years-
Gain YTD30.33518.721162%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.02B13.6B15%
Annual Yield % from dividends0.000.00-
Returns for 1 year35.3227.03131%
Returns for 3 years-4.913.97-124%
Returns for 5 years63.3370.8289%
Returns for 10 years224.34146.16153%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX29.410.38
+1.31%
Russell Inv US Small Cap Equity M
SLVIX37.460.31
+0.83%
Columbia Select Large Cap Value Inst2
RRFDX38.520.28
+0.73%
T. Rowe Price Equity Income R
GFVAX16.73N/A
N/A
Goldman Sachs Focused Value A
NALFX69.57N/A
N/A
New Alternatives A